Disability

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name…

2 months ago

South Korean Startup DoctorPresso Launches Groundbreaking App That Detects Depression Through Voice

A New Era of Mental Health: Meet REDI, the App That Listens for Depression SEOUL, South Korea, Sept. 12, 2024…

2 months ago

Veru to Present at the 2024 Cantor Global Healthcare Conference

MIAMI, FL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

2 months ago

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and…

2 months ago

Highmark First to Cover AppliedVR’s Flagship VR Device for Chronic Low Back Pain Treatment

FDA-authorized RelieVRx now a covered treatment for Highmark's commercial members experiencing chronic low back pain (CLBP) PITTSBURGH, Sept. 9, 2024…

3 months ago

Workday Sees Continued Momentum Across Healthcare, Driven By Demand for Solutions to Advance the Future of Health

Mid-Sized Healthcare Organizations Including Hebrew SeniorLife, Mary Free Bed Rehabilitation Hospital, Reid Health, Sea Mar Community Health, and More Select…

3 months ago

Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the…

3 months ago

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets…

3 months ago

George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at ESC Congress 2024

George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at…

3 months ago